Norquinol

Quick links to important sections

Norquinol

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norquinol

Property Description
Active Ingredients Norfloxacin, Broxyquinoline, Kaolin, Pectin
Form Oral Suspension or Tablet
Pharmacological Class Antidiarrheal Combination; Intestinal Anti-infective and Adsorbent
Common Use Acute Infectious Diarrhea
Origin Synthetic and Naturally Derived

Norquinol is defined as a complex, poly-component Fixed-Dose Combination (FDC) medicine specifically formulated to address acute intestinal issues, primarily infectious diarrhea. Its primary pharmacological classification is an Antidiarrheal Combination with key Intestinal Anti-infective and Adsorbent properties, a structured blend that aims to manage both the microbial cause and the physical symptoms of the condition concurrently.

What Type of Medicine is Norquinol?

Norquinol is an FDC product typically supplied as an Oral Suspension or Tablet for Oral Administration. This formulation, which integrates four distinct active substances, is designed to deliver multiple therapeutic actions compared to single-ingredient therapies. The inclusion of the fluoroquinolone antibacterial Norfloxacin means the product has a specific role in addressing the microbial etiology of diarrhea. This classification relates to the medicine's ability to act against susceptible bacteria.

Understanding the Composition of Norquinol: Synthetic and Natural Components

The medicine's efficacy is derived from four core active ingredients with both synthetic and naturally derived origins. The synthetic components are Norfloxacin and Broxyquinoline, an antiseptic from the halogenated quinoline class. These are combined with Kaolin, an intestinal adsorbent that binds toxins, and Pectin, a gastrointestinal protectant. The combination of antibacterial and adsorptive agents is intended for symptomatic relief by helping to reduce both the pathogen count and the physical irritants in the gut.

What is the General Therapeutic Purpose of Norquinol?

The general therapeutic purpose of Norquinol is to provide multifaceted management for acute infectious diarrhea, such as cases arising from common foodborne pathogens. The combined action aims to eliminate susceptible pathogens via bactericidal action while simultaneously promoting intestinal detoxification via the physical adsorption of irritants. This integrated approach is intended to help reduce the severity of symptoms and aid in the functional recovery of the digestive system.

What side effects are possible with Norquinol?

Possible side effects and safety information for Norquinol

Norquinol (Norfloxacin) is associated with a spectrum of officially documented adverse reactions, including disabling and potentially irreversible serious adverse reactions involving multiple body systems. Regulatory authorities have issued strong warnings regarding these serious risks.


Serious and Clinically Significant Adverse Reactions

Serious reactions can occur after the first dose and include, but are not limited to:

  • Tendon Rupture (most commonly Achilles tendon) and Tendinitis.
  • Peripheral Neuropathy (nerve damage) leading to numbness, tingling, burning pain, or weakness that may be permanent.
  • Central Nervous System Effects such as seizures, tremors, confusion, hallucinations, and serious psychiatric reactions (e.g., suicidal thoughts).
  • Worsening of Myasthenia Gravis (including respiratory failure).
  • Aortic Aneurysm and Dissection.
  • Serious Hypersensitivity Reactions (e.g., anaphylaxis, severe skin reactions).

Other Documented Adverse Reactions

Commonly reported side effects include nausea, headache, and dizziness. Less frequent documented reactions involve various system-organ classes, such as cardiac effects (QTc prolongation), gastrointestinal issues (Clostridium difficile-associated diarrhea), and photosensitivity/phototoxicity.


Safety Restrictions and Population-Specific Considerations

Norquinol is contraindicated in patients with a history of myasthenia gravis, or a history of tendinitis/tendon rupture associated with any quinolone.

Patients over 60 years of age, those with renal impairment, and those concurrently taking corticosteroids are at an increased risk for tendon rupture. The medicine is not established as safe or effective in pediatric patients due to the risk of bone and joint problems. Dosage adjustments are required for patients with impaired renal function.

Overdose and Emergency Response

Overdose and When to Seek Help

A Norquinol overdose is officially classified as a severe event with the documented potential for life-threatening outcomes. The clinical manifestations are primarily related to excessive systemic exposure to the Norfloxacin component, affecting the Central Nervous System, Renal, and Gastrointestinal systems.

Documented Manifestations and Outcomes

Regulatory information describes overdose presentations that include gastrointestinal distress (nausea, vomiting), CNS effects (dizziness, confusion, tremor, headache), and specific renal findings like crystalluria and hematuria. Severe outcomes listed in official prescribing information include the potential for convulsive seizures (or status epilepticus) and, in rare instances, severe cardiac effects. Patients with pre-existing renal impairment are documented as being at increased risk of elevated drug concentrations following an overdose.

Required Emergency Actions

Official regulatory guidance mandates that any suspected overdose requires the patient to seek immediate medical attention and contact emergency services immediately. Due to the severity classification and potential outcomes, hospital monitoring is required for an observation period. As no specific antidote is known, management is defined as symptomatic and supportive treatment. This may involve procedures like gastric lavage or activated charcoal to limit absorption, alongside required continuous ECG monitoring and renal function monitoring.

Therapeutic Uses of Norquinol

What Norquinol Treats: Main Uses and Benefits

Norquinol is commonly used in clinical settings that involve acute or disruptive symptom patterns associated with infectious diseases of the gut. The medication is commonly used to help manage acute infectious diarrhea, which includes common scenarios like traveler's diarrhea, foodborne illness, and other acute diarrheal disease where susceptible bacterial pathogens may be involved. Fluoroquinolones are considered relevant for the management of certain diarrheal episodes and are often applied during phases when symptoms become more noticeable.

The medication is relevant for managing the symptom cluster of high-frequency, loose stools, and abdominal cramping associated with acute gastroenteritis. By providing supportive symptomatic assistance, it helps address symptoms related to heightened physiological activity and physical discomfort. The combination provides support that helps ease the overall symptom burden and may help maintain a sense of stability when symptoms are more noticeable.

“This combined approach is relevant for managing symptoms that interfere with daily functioning and assists with supporting the acute condition.”

Quick Fact: Relief for Diarrhea and Abdominal Discomfort

The combination is used across therapeutic domains where additional symptomatic support is needed to address both the microbial cause and the acute manifestations of intestinal irritation.

Eligibility and Restrictions for Use

Who can and cannot use Norquinol?

Eligibility for Norquinol, a Fixed-Dose Combination containing the fluoroquinolone Norfloxacin, is strictly governed by official regulatory limitations on its active components. Use is primarily established for the adult population who are free of specific contraindications.


Populations For Whom Use Is Contraindicated:

Absolute Contraindications Age & Physiological Status
History of hypersensitivity to any quinolone or FDC component. Children and adolescents (under 18 years), as safety is not established.
History of tendinitis or tendon rupture related to quinolone use. Patients with a history of Myasthenia Gravis.

Populations Requiring Conditional or Restricted Use:

Use is not recommended or requires caution in several groups due to potential risks established in regulatory labeling. This includes patients with a history of seizures or other CNS disorders, as well as those with pre-existing cardiac conditions or prolonged QT interval. Caution is mandatory for older adults (typically geq 60 years) and those with impaired renal function (who require dosage adjustment), G6PD deficiency, or concurrent use of corticosteroids. Use during pregnancy and breastfeeding is generally not recommended.

What should I know about interactions with other medicines?

The official interaction profile for Norquinol is defined by constraints related to its multi-component formulation, specifically the pharmacokinetic actions of its adsorptive agents and the metabolic effects of Norfloxacin. This information is drawn directly from government regulatory sources.

Interactions Affecting Drug Exposure

The Kaolin and Pectin components can interfere with the systemic absorption of co-administered oral medications. This adsorption-based interference is documented to reduce the plasma concentration (exposure) of many oral drugs, including certain antibiotics, Digoxin, and Iron supplements. To mitigate this effect, official guidelines mandate a separation interval, requiring other oral medications be taken at least two to four hours before or after Norquinol.

Separately, the absorption of Norfloxacin is reduced by multivalent cations. Ingestion of dairy products or supplements containing aluminum, magnesium, or iron can chelate the fluoroquinolone, significantly lowering its effective plasma concentration.

Metabolic and Pharmacodynamic Risks

Norfloxacin is officially documented as an inhibitor of Cytochrome P450 1A2 (CYP1A2). This can reduce the clearance and increase the exposure of drugs metabolized by this pathway, such as Theophylline, necessitating monitoring. Co-administration with Tizanidine is prohibited as a formal contraindication due to the risk of Tizanidine toxicity resulting from this elevated exposure. Pharmacodynamic risks also exist, including documented warnings about increased central nervous system excitation when combined with Non-Steroidal Anti-inflammatory Drugs (NSAIDs) and an enhanced bleeding risk when co-administered with anticoagulants like Warfarin.

Mechanism of Action

Targeting the Bacterial DNA Management System

Norquinol is a bactericidal agent that works by disrupting essential functions of the bacterial cell. Its primary mechanism involves targeting and inhibiting two crucial bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. These enzymes are critical for handling the bacterial chromosome, including relieving DNA strain and separating daughter chromosomes during cell division. The drug binds to and traps these enzymes when they are attached to the DNA, preventing the DNA strands from re-ligating.

Inducing Lethal Genetic Cascades

The result of trapping these enzymes is the widespread accumulation of double-stranded DNA breaks throughout the bacterial genome, triggering an irreversible stress response. This destructive cascade immediately halts DNA replication and transcription, leading directly to the breakdown and physical death of the bacterial cell. This mechanism ensures a bactericidal effect, resulting in the physiological outcome of reducing the load of viable bacterial cells.

Constraints on Mechanistic Efficacy

The drug's intrinsic activity is constrained by bacterial defense mechanisms such as efflux pumps, which actively push Norquinol out of the cell, and mutations in the target enzymes (Gyrase and Topoisomerase IV) that prevent tight binding. These limitations interfere with the drug's ability to initiate the lethal cascade, which may result in a diminished bactericidal effect on the target population.

Dosage and Administration Information

How to use Norquinol

The official usage of Norquinol focuses on strict administration timing and dose integrity to ensure proper absorption of its antibacterial component. The medicine is supplied as an Oral Tablet or Oral Suspension for oral administration. The standard adult dosing regimen is typically 400 mg of the active antibacterial component taken twice daily, administered at approximately 12-hour intervals. The treatment duration for infections of the stomach or intestines is commonly a short course of 5 days.

Feature Official Labeled Guideline
Route of Administration Oral
Dosing Schedule 400 mg, twice daily (every 12 hours)
Timing with Food Take on an empty stomach, specifically 1 hour before or 2 hours after a meal or dairy products.
Special Condition Separate dose from polyvalent cations (e.g., antacids, iron supplements) by at least 2 hours before or 4 hours after the dose.
Renal Adjustment If severe renal impairment is present (creatinine clearance leq 30 mL/min), the frequency is reduced to 400 mg once daily.

Official procedural structure:

  • Timing: Administer the medicine at the specified time relative to food and milk products.
  • Preparation: Swallow the tablet with a full glass of water; if using the suspension, shake the liquid well before measuring.
  • Adherence: Complete the full course as prescribed.
  • Missed Dose: If a dose is missed and it is nearly time for the next dose, the missed dose should be skipped; a double dose is not to be taken.

This protocol governs the precise manner in which the medicine must be introduced into the body across a short-term, fixed-frequency schedule, ensuring adherence to the labeled use parameters.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Norquinol

Evidence for Use in Acute Infectious Diarrhea

Research has primarily focused on the core anti-infective component, Norfloxacin, which is an ingredient studied in the context of Norquinol's intended use. Studies conducted during periods of increased symptom activity, such as short-term Randomized Controlled Trials (RCTs), were used in research exploring how symptoms change over time in conditions associated with acute or disruptive episodes. These trials mainly involved adult travelers experiencing diarrhea or other adults with acute gastroenteritis.

The studies monitored outcomes related to functional imbalance, such as the total duration of diarrhea, and outcomes related to systemic strain, such as the rate at which susceptible bacteria were cleared from the stool. Studies examined outcomes related to the time interval until the last unformed stool, and patterns of measurement were recorded in the groups treated with Norfloxacin.

Dedicated comparative studies that include the specific four-component Fixed-Dose Combination (FDC) that makes up Norquinol are not consistently documented in the current evidence base. Comparative evidence that examines the specific contribution of combining Norfloxacin with Broxyquinoline, Kaolin, and Pectin, particularly against using Norfloxacin alone, remains limited. Certainty remains low regarding the full FDC's independent contribution to these primary anti-infective outcomes, as comprehensive comparative data are limited.


Evidence for Symptomatic Management of Diarrhea

Studies explored the use of Norquinol's components in managing acute or episodic symptom patterns, focusing on the roles of the adsorbent (Kaolin) and protectant (Pectin) agents. The trials were relevant in evidence describing how symptoms are measured, particularly outcomes related to physical discomfort like abdominal cramping, and outcomes related to functional limitations, such as changes in stool consistency and frequency. Research highlights changes measured during the study period in patient-reported outcomes describing perceived discomfort.

What is Still Uncertain About Norquinol Research

A key limitation is the absence of dedicated, large-scale comparative research on the precise four-component combination that defines Norquinol. Follow-up durations were limited across most trials, meaning long-term outcomes are not well characterized. Data for certain groups, such as children or older adults, remain insufficient, indicating that research provides limited insight into whether an individual outside these studied groups was observed to respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Norquinol (FAQ)


Q: Is Norquinol a penicillin-based antibiotic?

A: No. Official product information confirms that the active antibacterial component in Norquinol belongs to the fluoroquinolone class of antibiotics. This class is chemically distinct and works differently from penicillin-based antibiotics.

Q: Can I drink alcohol in moderation while taking Norquinol?

A: While regulatory documents do not list a formal contraindication for alcohol with Norquinol, caution is noted in general medical contexts. This is because the medication can cause central nervous system side effects like dizziness and confusion, which may be worsened by the effects of alcohol.

Q: Does Norquinol affect birth control pills?

A: Regulatory and professional guidance generally indicates that the antibacterial component of Norquinol, Norfloxacin, typically does not interfere with the effectiveness of most hormonal birth control pills. Information regarding all medications should be discussed with a healthcare provider.

Q: What are the signs of a serious side effect from Norquinol that needs immediate attention?

A: Serious adverse reactions that require immediate medical evaluation include sudden, severe pain in the chest, back, or abdomen, which could signal an aortic issue. Additionally, pain or swelling in tendons, or new symptoms like numbness, tingling, or weakness in the arms and legs (peripheral neuropathy) should prompt immediate contact with a healthcare professional or emergency services.

Q: Can Norquinol be used to treat bacterial skin infections?

A: The official therapeutic purpose of this Fixed-Dose Combination is primarily the treatment of acute infectious diarrhea. The medication is not specified in the labeled indications for common bacterial skin infections.

Q: Is Norquinol effective against all types of bacteria?

A: No. According to official product information, Norquinol is only effective against specific types of bacteria that are susceptible to the drug. Like all antibiotics, it will not work against bacteria that have developed resistance mechanisms.

Q: Do antacids interfere with the absorption of Norquinol?

A: Yes. Regulatory documents strongly advise that antacids and any supplements containing multivalent cations (e.g., aluminum, magnesium, iron) can significantly reduce the absorption and effectiveness of Norquinol. Because of this interaction, regulatory guidelines specify a separation interval of at least two to four hours between taking these products and the dose of Norquinol.

Q: What is the expected duration of the side effects after stopping Norquinol?

A: Most common side effects, such as headache or nausea, typically resolve soon after stopping the medication. However, official warnings note that some serious adverse reactions, particularly peripheral neuropathy (nerve damage) and tendon problems, have been reported to be persistent, long-lasting, or potentially irreversible in some individuals.

Q: Can Norquinol be taken during pregnancy?

A: Use of Norquinol during pregnancy is generally not recommended according to regulatory labeling. This precaution is based on potential risks to the fetus observed in animal studies. Decision to use this medication during pregnancy is based on a healthcare provider's assessment of the potential benefit versus the potential risk.

Q: Is Norquinol safe to use while breastfeeding?

A: Regulatory documents advise that use while breastfeeding is generally not recommended. This precaution is taken due to the potential for the drug to cause serious adverse reactions in a nursing infant. The decision regarding continuing the drug or continuing nursing should be guided by a healthcare provider.

Q: What should someone do if they accidentally take too much Norquinol?

A: Official guidance indicates that contact with a poison control center, doctor, or emergency department should be initiated immediately if there is a suspicion that too much Norquinol has been taken. This should be done right away, even if the individual feels well.

Q: Can I take ibuprofen or acetaminophen with Norquinol?

A: Official labeling advises caution with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen. Combining them with Norquinol may increase the risk of central nervous system effects, including seizures. Acetaminophen is not specifically cited as an interaction.

Q: Does Norquinol interact with blood thinners like Warfarin?

A: Yes, regulatory documents contain a specific warning about this interaction. Norquinol can increase the effect of anticoagulants like Warfarin, leading to an enhanced risk of bleeding. When these medications are co-administered, close monitoring may be recommended by a healthcare provider.

Q: What is the risk of Clostridium difficile infection (C. diff) with Norquinol?

A: Like almost all antibiotics, Norquinol can alter the normal balance of bacteria in the gut. Regulatory warnings note that this alteration can lead to the overgrowth of Clostridium difficile, potentially causing C. difficile-associated diarrhea (CDAD), which can range from mild to life-threatening.

Q: Does Norquinol require a prescription?

A: Yes. In the majority of countries, Norquinol (Norfloxacin) is legally classified as a Prescription Only Medicine. This means it is regulated and cannot be obtained without a valid doctor's prescription.

Q: Are there any known long-term side effects associated with Norquinol use?

A: Regulatory agencies have issued strong warnings regarding the possibility of long-lasting, persistent, or potentially irreversible serious adverse reactions. These concerns are specifically centered on tendon problems and nerve damage (peripheral neuropathy).

Q: How long does Norquinol stay in your system after the last dose?

A: The elimination of the drug is measured by its half-life, which is the time it takes for half of the drug to be eliminated from the body. The active component typically has a half-life of about 3 to 4 hours in adults with normal kidney function, and most of the drug is generally eliminated after several half-lives.

Q: Can Norquinol cause changes in mood or behavior?

A: Yes. Official product information notes that Norquinol has been associated with various Central Nervous System (CNS) effects. These can include new or increased feelings of anxiety, depression, and confusion, and in rare instances, serious psychiatric reactions like suicidal thoughts.

Q: Is Norquinol safe for people with a history of seizures?

A: Regulatory documents advise that patients with a history of seizures or other CNS disorders should use Norquinol with caution. The drug may increase the risk of CNS excitement, potentially leading to or worsening seizure activity.

Q: Is Norquinol available in different forms, such as liquid or injection?

A: The Fixed-Dose Combination product is commonly manufactured and distributed as an Oral Tablet or an Oral Suspension. These are the primary forms intended for its use in systemic intestinal infections.

Q: Does Norquinol interact with any common supplements like vitamins or minerals?

A: Yes. Regulatory documents confirm that Multivitamins and supplements containing key minerals like calcium, iron, magnesium, or zinc must be separated from the Norquinol dose. These minerals can interfere with the drug’s absorption and potentially reduce its effectiveness.

Q: Does Norquinol interact with caffeine or energy drinks?

A: Official information indicates that Norquinol can inhibit the enzyme that metabolizes (breaks down) caffeine. This can cause increased caffeine levels in the body, potentially leading to side effects like headache, nervousness, tremors, or insomnia.

Q: Why are people concerned about Norquinol causing antibiotic resistance?

A: Official guidance warns that the misuse or overuse of any antibiotic, including Norquinol, is a cause for concern. If the drug is not used correctly or unnecessarily, it can promote the development of bacteria that are no longer killed by the medicine, which is the process of antibiotic resistance.

Q: Can a patient with diabetes safely take Norquinol?

A: Patients with diabetes should use Norquinol with caution. Regulatory warnings note that the drug is associated with causing significant changes in blood sugar levels (potentially leading to either hypoglycemia or hyperglycemia). Close monitoring of blood sugar levels may be recommended by a healthcare professional while taking this medication.

Q: Is Norquinol used to treat traveler's diarrhea?

A: Yes. The active antibacterial component, Norfloxacin, is cited in professional guidelines and official product labeling as being recommended for the management of infectious diarrhea, which includes many cases of traveler's diarrhea.

Q: What should be done if vomiting occurs shortly after taking a dose of Norquinol?

A: Patient information generally advises that if vomiting occurs, simple steps like sticking to simple foods should be tried. If vomiting is severe or continuous, or there is concern about whether the dose was absorbed, contacting a doctor or pharmacist for guidance is recommended.

Q: Is Norquinol effective against prostate infections?

A: Yes. While the Fixed-Dose Combination is primarily used for infectious diarrhea, the active component, Norfloxacin, is a drug that has historically been and, in some regions, remains authorized for the treatment of infections of the prostate (prostatitis).

How should Norquinol be stored and disposed of?

How to Store and Dispose of Norquinol

Official Storage Requirements

Norquinol (Norfloxacin) must be stored at room temperature, typically between 15 C and 30 C (59 F to 86 F), with storage above 40 C strictly prohibited. The medicine must be kept in a tightly-closed container and protected from light, moisture, and freezing to maintain its stability. A mandatory requirement is to keep Norquinol out of the reach of children at all times.

Official Disposal Instructions

For disposal of unused or expired medicine, drug take-back programs are the preferred option as defined by regulatory agencies. If a take-back program is unavailable, Norquinol should not be flushed down the toilet or sink because it is not included on the FDA's flush list. Instead, the medicine must be mixed with an undesirable substance (like coffee grounds or dirt), sealed in a plastic bag or container, and placed into the household trash. Remember to scratch out all identifying information on the prescription label before discarding the original container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Norquinol found in:

A-Z Index: